Journal of Interventional Cardiac Electrophysiology

, Volume 55, Issue 3, pp 287–295 | Cite as

The use of a high-resolution mapping system may facilitate standard clinical practice in VE and VT ablation

  • Arian Sultan
  • Barbara BellmannEmail author
  • Jakob Lüker
  • Tobias Plenge
  • Jan-Hendrik van den Bruck
  • Karlo Filipovic
  • Susanne Erlhöfer
  • Liz Kuffer
  • Zeynep Arica
  • Daniel Steven



First experiences using a 64-electrode mini-basket catheter (BC) paired with an automatic mapping system (Rhythmia™) for catheter ablation (CA) of ventricular ectopy (VE) and ventricular tachycardia (VT) have been reported.


We aimed to evaluate (1) differences in ventricular access for the BC and (2) benefit of this technology in the setting of standard clinical practice.


Patients (pts) undergoing CA for VE or VT using the Intellamap Orion™ paired with the Rhythmia™ automated-mapping system were included in this study. For LV access, transseptal and retrograde access were compared.


All 32 pts (29 men, age 63 ± 15 years) underwent CA for VE (17 pts) or VT (15 pts). For mapping of VE originating from the left ventricle (LV) in 10 out of 13 pts, a transaortic access was feasible. The predominant access for CA of VT was transaortic (5/7). Feasibility and safety seem to be equal. The total procedure time was 179.1 ± 21.2 min for VE ablation and 212.0 ± 71.7 min for VT ablation (p = 0.177). For VE, an acquisition of 1602 ± 1672 map points and annotation of 140 ± 98 automated mapping points sufficed to abolish VE in all pts. During a 6-month follow-up (FU) after CA for VE, a VE burden reduction from 18.5 ± 2.1% to 2.8 ± 2.2% (p = 0.019) was achieved. In VT pts, one patient showed recurrence of sustained VT episodes during FU.


Use of a high-resolution mapping system for VE/VT CA potentially facilitates revelation of VE origin and VT circuits in the setting of standard clinical practice. Feasibility and safety of a venous, transaortic, transseptal, or a combined approach seem to be equal.


Ablation High-resolution mapping Ventricular tachycardia Ventricular ectopy 

Abbreviation list


Catheter ablation


Ventricular tachycardia


Ventricular ectopy


Mini-basket catheter


Left ventricular ejection fraction


Internal cardioverter defibrillator


Left ventricle


Right ventricle




Programmed ventricular stimulation


Follow up


Automated electrograms


Antiarrhythmic drug therapy


Congestive heart failure


Author contributions

Arian Sultan, MD: concept/design, data analysis/interpretation, drafting article, statistics, data collection.

Barbara Bellmann, MD: concept/design, data analysis/interpretation, drafting article, statistics, data collection.

Jakob Lüker, MD: data analysis/interpretation, critical revision of article, data collection.

Tobias Plenge, MD: critical revision of article, data collection.

Jan-Hendrik van den Bruck: critical revision of article, data collection.

Karlo Filipovic, MD: critical revision of article, data collection.

Susanne Erlhöfer, MD: critical revision of article, data collection.

Liz Kuffer, MD: critical revision of article, data collection.

Zeynep Arica: critical revision of article, data collection.

Daniel Steven, MD: concept/design, data analysis/interpretation, data collection.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for practice guidelines. J Am Coll Cardiol. 2006;48:247–346.CrossRefGoogle Scholar
  2. 2.
    Sacher F, Tedrow UB, Field ME, Raymond JM, Koplan BA, Epstein LM, et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol. 2008;1:153–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective Heart Centre of Leipzig VT (HELP-VT) study. Circulation. 2014;129:728–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm Society. J Am Coll Cardiol. 2018;72:e91–220.Google Scholar
  5. 5.
    Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793–867.CrossRefPubMedGoogle Scholar
  6. 6.
    Santangeli P, Frankel DS, Marchlinski FE. End points for ablation of scar-related ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:949–60.CrossRefPubMedGoogle Scholar
  7. 7.
    Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657–65.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tung R, Mathuria NS, Nagel R, Mandapati R, Buch EF, Bradfield JS, et al. Impact of local ablation on interconnected channels within ventricular scar: mechanistic implications for substrate modification. Circ Arrhythm Electrophysiol. 2013;6:1131–8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Tschabrunn CM, Roujol S, Dorman NC, Nezafat R, Josephson ME, Anter E. High-resolution mapping of ventricular scar: comparison between single and multielectrode catheters. Circ Arrhythm Electrophysiol. 2016;9:10.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Viswanathan K, Mantziari L, Butcher C, Hodkinson E, Lim E, Khan H, et al. Evaluation of a novel high-resolution mapping-system for catheter ablation of ventricular arrhythmias. Heart Rhythm. 2017;14:176–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Mantziari L, Butcher C, Kontogeorgis A, Panikker S, Roy K, Markides V, et al. Utility of a novel rapid high-resolution mapping-system in the catheter ablation of arrhythmias. JACC: Clini Electrophysiol. 2015;1:411–20.Google Scholar
  12. 12.
    Fernández-Armenta J, Penela D, Acosta J, Andreu D, Evertz R, Cabrera M, et al. Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study. Heart Rhythm. 2016;13:1589–95.CrossRefPubMedGoogle Scholar
  13. 13.
    Martínez-Rubio A, Kuschyk J, Sierra G, Breithardt G, Borggrefe M. Programmed ventricular stimulation: influence of early versus late introduction of a third extrastimulus, a randomized, prospective study. Europace. 2002;4:77–85.CrossRefPubMedGoogle Scholar
  14. 14.
    Pluta S, Lenarczyk R, Pruszkowska-Skrzep P, Kowalski O, Sokal A, Sredniawa B, et al. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter-defibrillator and electrical storm. J Interv Card Electrophysiol. 2010;28:45–50.CrossRefPubMedGoogle Scholar
  15. 15.
    Tilz RR, Makimoto H, Lin T, Rillig A, Metzner A, Mathew S, et al. In vivo left-ventricular contact force analysis: comparison of antegrade transseptal with retrograde transaortic mapping strategies and correlation of impedance and electrical amplitude with contact force. Europace. 2014;16:1387–95.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Steven D, van den Bruck JH, Lüker J, Plenge T, Sultan A. 3-D mapping of ventricular tachycardia in patients with dilative cardiomyopathy. Herzschrittmacherther Elektrophysiol. 2017;28:206–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Kaiser L, Jularic M, Akbulak RÖ, Nührich J, Willems S, Meyer C. Catheter ablation of hemodynamically unstable ventricular tachycardia in ischemic cardiomyopathy using high-resolution mapping. Clin Case Rep. 2017;5:389–93.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Takigawa M, Frontera A, Thompson N, Capellino S, Jais P, Sacher F. The electrical circuit of a hemodynamically unstable and recurrent ventricular tachycardia diagnosed in 35 s with the Rhythmia mapping-system. J Arrhythm. 2017;33:505–7.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Maagh P, Christoph A, Müller MS, Dopp H, Plehn G, Meissner A. Point-by-point versus multisite electrode mapping in VT ablation: does freedom from VT recurrences depend on mapping catheter? An observational study. J Interv Card Electrophysiol. 2018;51:169–81. Scholar
  20. 20.
    Wolf M, Sacher F, Cochet H, Kitamura T, Takigawa M, Yamashita S, et al. Long-term outcome of substrate modification in ablation of post-myocardial infarction ventricular tachycardia. Circ Arrhythm Electrophysiol. 2018;11:e005635. Scholar
  21. 21.
    Andreu D, Penela D, Acosta J, Fernández-Armenta J, Perea RJ, Soto-Iglesias D, et al. Cardiac magnetic resonance-aided scar dechanneling: influence on acute and long-term outcomes. Heart Rhythm. 2017;14:1121–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Arian Sultan
    • 1
  • Barbara Bellmann
    • 1
    Email author
  • Jakob Lüker
    • 1
  • Tobias Plenge
    • 1
  • Jan-Hendrik van den Bruck
    • 1
  • Karlo Filipovic
    • 1
  • Susanne Erlhöfer
    • 1
  • Liz Kuffer
    • 1
  • Zeynep Arica
    • 1
  • Daniel Steven
    • 1
  1. 1.Department of ElectrophysiologyUniversity of CologneKölnGermany

Personalised recommendations